Colorectal cancer patients under 50
You probably didn't see it coming, but you are not alone in your diagnosis. Below are helpful resources to guide your path to survivorship as a patient under age 50.
What you should know as a patient under 50
The incidence rate of colorectal cancer is rising by about two percent annually in people under age 50.
Learn more here about young-onset risks, treatment, and support.
Young-onset resources
As a young-onset colorectal cancer patient, you will face unique challenges. Use these resources to help guide you on your path to survivorship.
What is colorectal cancer?
Get started by learning the basics about colorectal cancer.
Young-onset
You're never too young for colorectal cancer. Learn more about young- onset colorectal cancer and ways to educate yourself about the risks of this disease.
Never too young program
Our Never Too Young (N2Y) Program, with the support of a dedicated Taskforce, is changing how the world sees this disease. Together, we’re increasing awareness, building a community, and learning more about young-onset colorectal cancer.
Your nation of allies is growing
From online group chat and our private Facebook page to financial assistance and navigators –we have a the right kind of support for everyone who needs it.
Our helpline is here for you
Our Helpline is free and available to support you. Helpline staff members are certified patient and family support navigators who have walked in your shoes and are ready to listen and answer any questions.
Finding clinical trials
Finding a clinical trial can be intimidating, but we are here to help you explore your options and help you prepare a list of trials to take to your doctor.
Up Next
Colorectal cancer under 50Top resources
Where breakthroughs begin: Project Cure CRC spotlight on Dr. Lisa Mielke
hrough Project Cure CRC, the Alliance is fueling bold, early-stage research with the potential to transform colorectal cancer treatment. Dr. Lisa Mielke’s groundbreaking work explores how the gut’s immune system and nerve signaling influence cancer growth—opening the door to new therapeutic approaches, including repurposed existing drugs. This is what’s possible when promising ideas get the support they need to move forward.
John E.: Biomarker testing uncovered a pivotal treatment option
After a grim prognosis, biomarker testing revealed a targeted treatment option for John E. Learn how knowing your biomarkers can change what’s possible.
2025 Walk series inspired allies across the country
Across nine cities nationwide, our community showed what’s possible when compassion, determination, and action meet on the pavement to #WalkLoud.
